Global Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026

October 2022 | 58 pages | ID: GF8C3338E731EN
MarketLine

Abstracts

Global Biotechnology Market @Summary, Competitive Analysis and Forecast, 2017-2026

SUMMARY

Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY HIGHLIGHTS

• The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
• The global biotechnology market had total revenues of $743.3 billion in 2021, representing a compound annual growth rate (CAGR) of 13.5% between 2016 and 2021.
• The medical/healthcare segment generated the most revenue in 2021, with total revenues of $422.1 billion, equivalent to 56.8% of the market's overall value.
• The US market is by far the largest globally, accounting for 38.7% of its total value in 2021. Comparatively, the entire Asia-Pacific and European regions accounted for 33.6% and 21.3% of the global market’s value respectively.

SCOPE

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the global
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global biotechnology market
• Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the Global biotechnology market with five year forecasts

REASONS TO BUY

• What was the size of the Global biotechnology market by value in 2021?
• What will be the size of the Global biotechnology market in 2026?
• What factors are affecting the strength of competition in the Global biotechnology market?
• How has the market performed over the last five years?
• What are the main segments that make up the global's biotechnology market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Category segmentation
4.2. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What has been the rationale behind recent M&A activity?

8 COMPANY PROFILES

8.1. Johnson & Johnson
8.2. F. Hoffmann-La Roche Ltd
8.3. BioNTech SE
8.4. Bayer AG
8.5. Novartis AG
8.6. Takeda Pharmaceutical Company Limited

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Global biotechnology industry value: $ billion, 2016–21
Table 2: Global biotechnology industry category segmentation: % share, by value, 2016–2021
Table 3: Global biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: Global biotechnology industry geography segmentation: $ billion, 2021
Table 5: Global biotechnology industry value forecast: $ billion, 2021–26
Table 6: Johnson & Johnson: key facts
Table 7: Johnson & Johnson: Annual Financial Ratios
Table 8: Johnson & Johnson: Key Employees
Table 9: Johnson & Johnson: Key Employees Continued
Table 10: F. Hoffmann-La Roche Ltd: key facts
Table 11: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 12: F. Hoffmann-La Roche Ltd: Key Employees
Table 13: BioNTech SE: key facts
Table 14: BioNTech SE: Annual Financial Ratios
Table 15: BioNTech SE: Key Employees
Table 16: Bayer AG: key facts
Table 17: Bayer AG: Annual Financial Ratios
Table 18: Bayer AG: Key Employees
Table 19: Bayer AG: Key Employees Continued
Table 20: Novartis AG: key facts
Table 21: Novartis AG: Annual Financial Ratios
Table 22: Novartis AG: Key Employees
Table 23: Novartis AG: Key Employees Continued
Table 24: Takeda Pharmaceutical Company Limited: key facts
Table 25: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 26: Takeda Pharmaceutical Company Limited: Key Employees
Table 27: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 28: Global exchange rate, 2017–21

List Of Figures

LIST OF FIGURES

Figure 1: Global biotechnology industry value: $ billion, 2016–21
Figure 2: Global biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: Global biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: Global biotechnology industry value forecast: $ billion, 2021–26
Figure 5: Forces driving competition in the global biotechnology industry, 2021
Figure 6: Drivers of buyer power in the global biotechnology industry, 2021
Figure 7: Drivers of supplier power in the global biotechnology industry, 2021
Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology industry, 2021
Figure 9: Factors influencing the threat of substitutes in the global biotechnology industry, 2021
Figure 10: Drivers of degree of rivalry in the global biotechnology industry, 2021